Clearpoint Neuro vs Sanuwave Health
Sanuwave Health is the larger business, with $44.1m of revenue in fiscal 2025 against $37.0m for Clearpoint Neuro (1.2 times as much). Sanuwave Health grew faster (35.0% against 17.8%). Sanuwave Health kept more of each dollar of sales as profit: a net margin of 26.8% against -69.1%.
| Latest fiscal year | Clearpoint NeuroCLPT, 2025 | Sanuwave HealthSNWV, 2025 |
|---|---|---|
| Revenue | $37.0m | $44.1m |
| Revenue growth | 17.8% | 35.0% |
| Net income | −$25.5m | $11.8m |
| Operating margin | — | 11.2% |
| Net margin | -69.1% | 26.8% |
| Return on equity | -95.6% | — |
| Free cash flow | −$24.4m | $1.9m |
| Cash | $45.9m | $12.0m |
| Total debt | $50.9m | $22.2m |
| Debt to equity | — | 1372.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 172 | 55 |
| Market value | $310m | $51.4m |
| Price vs our value range | — | — |
| Moat score | 30 (Weak) | 33 (Weak) |
| Insider trades, 12 months | 0 buys, 9 sales | 0 buys, 21 sales |